These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 22914582

  • 1. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E, Cohan D.
    AIDS; 2013 Jan 02; 27(1):F1-5. PubMed ID: 22914582
    [Abstract] [Full Text] [Related]

  • 2. What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review.
    Krakower D, Mayer KH.
    Ann Intern Med; 2012 Oct 02; 157(7):490-7. PubMed ID: 22821365
    [Abstract] [Full Text] [Related]

  • 3. Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.
    Li J, Dufrene SL, Okulicz JF.
    Ann Pharmacother; 2014 Apr 02; 48(4):507-18. PubMed ID: 24473492
    [Abstract] [Full Text] [Related]

  • 4. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM, Mayer KH.
    AIDS Patient Care STDS; 2011 Feb 02; 25(2):63-71. PubMed ID: 21284497
    [Abstract] [Full Text] [Related]

  • 5. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
    Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR.
    PLoS Med; 2013 Feb 02; 10(9):e1001511. PubMed ID: 24058300
    [Abstract] [Full Text] [Related]

  • 6. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?
    Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y.
    Am J Obstet Gynecol; 2015 Sep 02; 213(3):341.e1-12. PubMed ID: 25979615
    [Abstract] [Full Text] [Related]

  • 7. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.
    Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR, Sloan CE, Sax PE, Walensky RP.
    Clin Infect Dis; 2009 Mar 15; 48(6):806-15. PubMed ID: 19193111
    [Abstract] [Full Text] [Related]

  • 8. FDA treads carefully with PrEP.
    Holmes D.
    Lancet Infect Dis; 2012 Jul 15; 12(7):515-6. PubMed ID: 22930826
    [No Abstract] [Full Text] [Related]

  • 9. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Aug 10; 61(31):586-9. PubMed ID: 22874836
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preexposure prophylaxis for HIV prevention: where have we been and where are we going?
    Baeten JM, Haberer JE, Liu AY, Sista N.
    J Acquir Immune Defic Syndr; 2013 Jul 10; 63 Suppl 2(0 2):S122-9. PubMed ID: 23764623
    [Abstract] [Full Text] [Related]

  • 12. HIV preexposure prophylaxis in the real world.
    Daskalakis DC.
    Top Antivir Med; 2014 Jul 10; 22(4):670-5. PubMed ID: 25398067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.
    Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, Matheson T, Trainor N, Blue RW, Estrada Y, Coleman ME, Elion R, Castro JG, Chege W, Philip SS, Buchbinder S, Kolber MA, Liu AY.
    J Acquir Immune Defic Syndr; 2015 Apr 01; 68(4):439-48. PubMed ID: 25501614
    [Abstract] [Full Text] [Related]

  • 15. [HIV preexposure prophylaxis].
    Olczak A, Grabczewska E.
    Przegl Epidemiol; 2012 Apr 01; 66(1):79-82. PubMed ID: 22708303
    [Abstract] [Full Text] [Related]

  • 16. Considerations regarding antiretroviral chemoprophylaxis in MSM.
    Poynten IM, Zablotska I, Grulich AE.
    Curr Opin HIV AIDS; 2012 Nov 01; 7(6):549-56. PubMed ID: 22918448
    [Abstract] [Full Text] [Related]

  • 17. Use of antiretrovirals for HIV prevention: what do we know and what don't we know?
    Baeten JM, Grant R.
    Curr HIV/AIDS Rep; 2013 Jun 01; 10(2):142-51. PubMed ID: 23494772
    [Abstract] [Full Text] [Related]

  • 18. Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care Perspective.
    Conniff J, Evensen A.
    J Am Board Fam Med; 2016 Jun 01; 29(1):143-51. PubMed ID: 26769887
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR.
    J Acquir Immune Defic Syndr; 2012 Apr 15; 59(5):463-8. PubMed ID: 22267018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.